The Times They are A-Changin´: On Cannabinoids and Psychedelics´ Therapeutic Potential and Social Impact: A Therapeutic Revolution: Volume 296 (Progress in Brain Research, Volume 296) - Hardcover

 
9780443347672: The Times They are A-Changin´: On Cannabinoids and Psychedelics´ Therapeutic Potential and Social Impact: A Therapeutic Revolution: Volume 296 (Progress in Brain Research, Volume 296)

Inhaltsangabe

Cannabinoids and Psychedelics: A Therapeutic Revolution, Volume 296 offers original research, reviews, and essays, including basic science and clinical studies on cannabinoids and psychedelics. This includes basic works on the neurotransmitter systems, the effects of drugs on animal and human perception, and emotion and cognition. Chapters in this new release include Chemical diversity, receptor binding affinity and pharmacology of phytocannabinoids: insights into neuronal mechanisms, Does cannabis work for insomnia?, Testing NPSs as harm reduction strategies, Cannabis-based products in Brazil: regulation for quality improvement, Anti-prohibitionist social movement in Brazil and the strength of the Marijuana Marches, and much more. Other chapters include discussions on Philopsychedelia: The Reflorescence of Psychedelic Philosophy, Psychedelics in Palliative Care: Transcending Death and Alleviating Spiritual Suffering, High dreams: inhaled DMT increase lucid dreams and nightmares, Malaise in the psychedelic revolution: when and for whom this movement brings opportunities, and the Neurophenomenology of psychedelic-induced mystical experiences.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorinnen und Autoren

Sergio Mota-Rolim studied Medicine at the Federal University of Rio Grande do Norte - UFRN (1998-2004), with undergraduate research in sleep, memory and anxiety. He did a M.Sc. in Neuroscience by the Federal University of São Paulo (2005-2007), working with the influence of biological rhythms in sleep and memory. He have a Ph.D. in Neuroscience by UFRN (2008-2012), investigating the epidemiological, cognitive-behavioral and neurophysiological aspects of lucid dreaming. He did a first post-doc at the Brain Institute and Onofre Lopes University Hospital (UFRN) (2013-2019), testing DMT for treatment-resistant depression. He is currently in a second post-doc working with sleep and COVID at the International COVID sleep study (ICOSS) (2020-2025).

Renato Filev studied Biological Sciences - Medical Modality at the Universidade Federal de São Paulo - UNIFESP (2005-2008), with undergraduate research in alcohol, electroacupuncture and cannabinoids in rodent models. He have a Ph.D. in Neuroscience by UNIFESP (2010-2015), investigating the cannabinoids in behavioral models induced by drugs of abuse, He is currently does a post-doc study at the Department of Psychiatry in UNIFESP (2020-now), coordinating clinical trials with psychedelic and cannabinoid drugs for substance use disorder.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.